Peripheral Neuropathy Trial, Recruiting NCT06029075 Sponsor: The University of Texas Health Science Center, Houston Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06029075
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have neuropathic pain (nerve pain) following a traumatic spinal cord injury, an amputation, or a brain injury
  • People whose pain has been ongoing for more than 3 months
  • People between 18 and 75 years of age
  • People whose oral pain medications have not changed for at least two weeks, and who would continue taking the same medications during the trial

Who may not be able to join:

  • People whose oral pain medications are currently being adjusted
  • People whose pain is not neuropathic — for example, pain caused by inflammation at a wound or a neuroma (a type of nerve growth)
  • People who have a pacemaker, metal implants, or who require supplemental oxygen
  • People who have had an amputation of one or both arms
  • People whose arm muscles do not respond to TMS (a type of brain stimulation used in the trial) (confirm with trial site)
  • People who are unable to follow instructions or provide their own consent
  • People who have asthma or another lung condition
  • People who are not currently in a stable medical condition
  • People who have a pre-existing psychiatric disorder
  • People with a history of alcohol or drug abuse

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sheng Li, MD, Ph.D, The University of Texas Health Science Center, Houston

Phone: (713) 797-7125

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
30 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Pain scale (visual analogue scale, VAS) measurement; Heart rate variability (HRV) measurement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov